TELOMIR PHARMACEUTICALS INC
TELO · NASDAQ
Updated at 2026-10-14 09:20:46
- Today's High
- $1.20
- Today’s Low
- $1.07
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.13
- Previous Close
- $1.10
- Volume
- 70.86K
- Market Cap
- $80.98M
- P/E Ratio
- --
- EPS
- $-0.15
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 100 SE 2ND STREET, MIAMI, FL, UNITED STATES, 33131
- Country
- US
- Listing Date
- 2024-02-09
- Fiscal Year End
- September
- Shares Outstanding
- 68.77M
- CIK
- 0001971532
- Website
- telomirpharma.com
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. The company is headquartered in Baltimore, Maryland.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$1.76M
2026-03-31
$1.04M
2025-12-31
$2.13M
2025-09-30
$1.14M
Net Income
2026-06-30
-$1.72M
2026-03-31
-$990.94K
2025-12-31
-$2.06M
2025-09-30
-$1.1M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.79
2026-03-31
$-0.02
2025-12-31
$-0.06
2025-09-30
$-0.03
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$1.71M
2026-03-31
-$989.69K
2025-12-31
-$2.06M
2025-09-30
-$1.09M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $1.76M | $1.04M | $2.13M | $1.14M |
| Net Income | -$1.72M | -$990.94K | -$2.06M | -$1.1M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.79 | $-0.02 | $-0.06 | $-0.03 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$1.71M | -$989.69K | -$2.06M | -$1.09M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.